NORTH AMERICA STEM CELL MARKET 2021-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,500	205 Pages	Triton Market Research	December, 2020	TRTN16847699

Best Price Guarantee
Price	from $1,500
Length	205 Pages
Publisher	Triton Market Research
Published Date	December, 2020
SKU	TRTN16847699

NORTH AMERICA STEM CELL MARKET 2021-2028

MARKET OUTLOOK

The report by Triton Market Research denotes that the stem cell market in North America is likely to gather a CAGR of 7.41% in the studied years 2021-2028. The United States and Canada form the overall region.

In North America, the market is mainly motivated by the rise in investment in research and development activities in stem cell and other pharmaceuticals. Moreover, the growing cases of chronic diseases, including heart conditions and cancers, are significantly driving the stem cell market across the region.

In the United States, for instance, the number of cancer cases have proliferated, which has influenced leading companies to focus on R&D activities to initiate new stem cell therapies in treating such conditions. This contributes significantly to the evolution of the studied market. Additionally, the country has a well-established healthcare sector, with a large number of products set in line for stem cell therapies. Above all, several research activities are undertaken by market players to develop a treatment for limiting the spread of COVID-19. Thus, the rising R&D activities for developing novel cell therapies are likely to accelerate the stem cell market’s progression across the United States.

Canada is another country that is leading based on stem cell research. Moreover, Canadian researchers have initiated stem cell therapy in the healthcare industry, which has saved several lives over the years. Besides, the country faces high incidences of heart conditions, which further offers companies several opportunities to launch efficient stem cell therapies. Hence, the growing prevalence of chronic diseases and research activities, are likely to fuel the stem cell market’s expansion.

COMPETITIVE OUTLOOK

The major market players in the stem cell market comprise GE Healthcare, International Stem Cell Corp, Thermo Fisher Scientific Inc, StemCell Technologies, Cytori Therapeutics, Takara Holdings, and Miltenyi Biotec.

1. NORTH AMERICA STEM CELL MARKET - SUMMARY
2. INDUSTRY OUTLOOK: 2.1. PORTER’S FIVE FORCES MODEL; 2.1.1. THREAT OF NEW ENTRANTS; 2.1.2. THREAT OF SUBSTITUTE PRODUCTS; 2.1.3. BARGAINING POWER OF BUYERS; 2.1.4. BARGAINING POWER OF SUPPLIERS; 2.1.5. COMPETITIVE RIVALRY; 2.2. IMPACT OF COVID-19 ON STEM CELL MARKET; 2.3. KEY IMPACT ANALYSIS; 2.4. INDUSTRY COMPONENTS; 2.5. LEGAL, POLICY, & REGULATORY FRAMEWORK; 2.6. MARKET ATTRACTIVENESS INDEX; 2.7. VENDOR SCORECARD; 2.8. KEY INSIGHTS; 2.9. MARKET DRIVERS; 2.9.1. GROWING AWARENESS ABOUT UMBILICAL CORD STEM CELLS; 2.9.2. SURGE IN STEM CELL RESEARCH AND DEVELOPMENT; 2.9.3. RISING DEMAND FOR REGENERATIVE MEDICINE; 2.10. MARKET RESTRAINTS; 2.10.1. ETHICAL CONCERNS ASSOCIATED WITH STEM CELLS; 2.10.2. HIGH COST OF STEM CELL PROCEDURES; 2.10.3. STRINGENT REGULATIONS IN TERMS OF STEM CELL THERAPY; 2.11. MARKET OPPORTUNITIES; 2.11.1. ADVANCEMENT IN TECHNOLOGY; 2.11.2. RISK OF ADVERSE IMMUNE REACTIONS AND COMPLICATIONS
3. NORTH AMERICA STEM CELL MARKET OUTLOOK - BY THERAPEUTIC APPLICATION: 3.1. NEUROLOGICAL DISORDERS; 3.2. ONCOLOGY DISORDERS; 3.3. DIABETES; 3.4. INJURIES AND WOUNDS; 3.5. ORTHOPEDIC TREATMENTS; 3.6. CARDIOVASCULAR DISORDERS; 3.7. OTHER THERAPEUTIC APPLICATIONS
4. NORTH AMERICA STEM CELL MARKET OUTLOOK - BY TECHNOLOGY: 4.1. CRYOPRESERVATION; 4.2. ACQUISITION; 4.2.1. STEM CELL APHERESIS; 4.2.2. STEM CELL BONE MARROW MARKET; 4.2.3. STEM CELL UMBILICAL CORD; 4.3. EXPANSION AND SUB-CULTURE; 4.4. PRODUCTION; 4.4.1. STEM CELL CULTURE; 4.4.2. THERAPEUTIC CLONING; 4.4.3. IVF
5. NORTH AMERICA STEM CELL MARKET OUTLOOK - BY TREATMENT TYPE: 5.1. ALLOGENEIC STEM CELL THERAPY; 5.2. AUTOLOGIC STEM CELL THERAPY; 5.3. SYNGENEIC STEM CELL THERAPY
6. NORTH AMERICA STEM CELL MARKET OUTLOOK - BY PRODUCT: 6.1. ADULT STEM CELL; 6.1.1. HEMATOPOIETIC STEM CELL; 6.1.2. NEURAL STEM CELL; 6.1.3. UMBILICAL CORD STEM CELL; 6.1.4. MESENCHYMAL STEM CELL; 6.1.5. DENTAL STEM CELL; 6.2. HUMAN EMBRYONIC STEM CELL; 6.3. PLURIPOTENT; 6.4. MOUSE/RAT NEURAL
7. NORTH AMERICA STEM CELL MARKET OUTLOOK - BY APPLICATION: 7.1. REGENERATIVE MEDICINE; 7.2. DRUG DISCOVERY AND DEVELOPMENT
8. GEOGRAPHICAL ANALYSIS - NORTH AMERICA: 8.1. COUNTRY ANALYSIS; 8.1.1. THE UNITED STATES; 8.1.2. CANADA
9. COMPANY PROFILES: 9.1. CORNING INC; 9.2. STEMCELL TECHNOLOGIES; 9.3. STRYKER CORPORATION; 9.4. BECTON DICKINSON AND COMPANY (BD); 9.5. CYTORI THERAPEUTICS; 9.6. QIAGEN NV; 9.7. GE HEALTHCARE; 9.8. TAKARA HOLDINGS; 9.9. SMITH & NEPHEW PLC; 9.10. INTERNATIONAL STEM CELL CORP; 9.11. MILTENYI BIOTEC; 9.12. MERCK KGAA (SIGMA ALDRICH); 9.13. THERMO FISHER SCIENTIFIC INC; 9.14. ALLCELLS LLC; 9.15. PLURISTEM THERAPEUTICS INC; 10. RESEARCH METHODOLOGY & SCOPE; 10.1. RESEARCH SCOPE & DELIVERABLES; 10.1.1. OBJECTIVES OF STUDY; 10.1.2. SCOPE OF STUDY; 10.2. SOURCES OF DATA; 10.2.1. PRIMARY DATA SOURCES; 10.2.2. SECONDARY DATA SOURCES; 10.3. RESEARCH METHODOLOGY; 10.3.1. EVALUATION OF PROPOSED MARKET; 10.3.2. IDENTIFICATION OF DATA SOURCES; 10.3.3. ASSESSMENT OF MARKET DETERMINANTS; 10.3.4. DATA COLLECTION; 10.3.5. DATA VALIDATION & ANALYSIS; LIST OF TABLES; TABLE 1 NORTH AMERICA STEM CELL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION); TABLE 2 VENDOR SCORECARD; TABLE 3 NORTH AMERICA STEM CELL MARKET, BY THERAPEUTIC APPLICATION, 2021-2028 (IN $ MILLION); TABLE 4 NORTH AMERICA STEM CELL MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION); TABLE 5 NORTH AMERICA ACQUISITION MARKET, BY TYPE, 2021-2028 (IN $ MILLION); TABLE 6 NORTH AMERICA PRODUCTION MARKET, BY TYPE, 2021-2028 (IN $ MILLION); TABLE 7 NORTH AMERICA STEM CELL MARKET, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION); TABLE 8 NORTH AMERICA STEM CELL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION); TABLE 9 NORTH AMERICA ADULT STEM CELL MARKET, BY TYPE, 2021-2028 (IN $ MILLION); TABLE 10 NORTH AMERICA STEM CELL MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION); TABLE 11 NORTH AMERICA STEM CELL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION); LIST OF FIGURES; FIGURE 1 NORTH AMERICA STEM CELL MARKET 2021-2028 (IN $ MILLION); FIGURE 2 NORTH AMERICA STEM CELL MARKET, BY NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION); FIGURE 3 NORTH AMERICA STEM CELL MARKET, BY ONCOLOGY DISORDERS, 2021-2028 (IN $ MILLION); FIGURE 4 NORTH AMERICA STEM CELL MARKET, BY DIABETES, 2021-2028 (IN $ MILLION); FIGURE 5 NORTH AMERICA STEM CELL MARKET, BY INJURIES AND WOUNDS, 2021-2028 (IN $ MILLION); FIGURE 6 NORTH AMERICA STEM CELL MARKET, BY ORTHOPEDIC TREATMENTS, 2021-2028 (IN $ MILLION); FIGURE 7 NORTH AMERICA STEM CELL MARKET, BY CARDIOVASCULAR DISORDERS, 2021-2028 (IN $ MILLION); FIGURE 8 NORTH AMERICA STEM CELL MARKET, BY OTHER THERAPEUTIC APPLICATIONS, 2021-2028 (IN $ MILLION); FIGURE 9 NORTH AMERICA STEM CELL MARKET, BY CRYOPRESERVATION, 2021-2028 (IN $ MILLION); FIGURE 10 NORTH AMERICA STEM CELL MARKET, BY ACQUISITION, 2021-2028 (IN $ MILLION); FIGURE 11 NORTH AMERICA STEM CELL MARKET, BY STEM CELL APHERESIS, 2021-2028 (IN $ MILLION); FIGURE 12 NORTH AMERICA STEM CELL MARKET, BY STEM CELL BONE MARROW MARKET, 2021-2028 (IN $ MILLION); FIGURE 13 NORTH AMERICA STEM CELL MARKET, BY STEM CELL UMBILICAL CORD, 2021-2028 (IN $ MILLION); FIGURE 14 NORTH AMERICA STEM CELL MARKET, BY EXPANSION AND SUB-CULTURE, 2021-2028 (IN $ MILLION); FIGURE 15 NORTH AMERICA STEM CELL MARKET, BY PRODUCTION, 2021-2028 (IN $ MILLION); FIGURE 16 NORTH AMERICA STEM CELL MARKET, BY STEM CELL CULTURE, 2021-2028 (IN $ MILLION); FIGURE 17 NORTH AMERICA STEM CELL MARKET, BY THERAPEUTIC CLONING, 2021-2028 (IN $ MILLION); FIGURE 18 NORTH AMERICA STEM CELL MARKET, BY IVF, 2021-2028 (IN $ MILLION); FIGURE 19 NORTH AMERICA STEM CELL MARKET, BY ALLOGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION); FIGURE 20 NORTH AMERICA STEM CELL MARKET, BY AUTOLOGIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION); FIGURE 21 NORTH AMERICA STEM CELL MARKET, BY SYNGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION); FIGURE 22 NORTH AMERICA STEM CELL MARKET, BY ADULT STEM CELL, 2021-2028 (IN $ MILLION); FIGURE 23 NORTH AMERICA STEM CELL MARKET, BY HEMATOPOIETIC STEM CELL, 2021-2028 (IN $ MILLION); FIGURE 24 NORTH AMERICA STEM CELL MARKET, BY NEURAL STEM CELL, 2021-2028 (IN $ MILLION); FIGURE 25 NORTH AMERICA STEM CELL MARKET, BY UMBILICAL CORD STEM CELL, 2021-2028 (IN $ MILLION); FIGURE 26 NORTH AMERICA STEM CELL MARKET, BY MESENCHYMAL STEM CELL, 2021-2028 (IN $ MILLION); FIGURE 27 NORTH AMERICA STEM CELL MARKET, BY DENTAL STEM CELL, 2021-2028 (IN $ MILLION); FIGURE 28 NORTH AMERICA STEM CELL MARKET, BY HUMAN EMBRYONIC STEM CELL, 2021-2028 (IN $ MILLION); FIGURE 29 NORTH AMERICA STEM CELL MARKET, BY PLURIPOTENT, 2021-2028 (IN $ MILLION); FIGURE 30 NORTH AMERICA STEM CELL MARKET, BY MOUSE/RAT NEURAL, 2021-2028 (IN $ MILLION); FIGURE 31 NORTH AMERICA STEM CELL MARKET, BY REGENERATIVE MEDICINE, 2021-2028 (IN $ MILLION); FIGURE 32 NORTH AMERICA STEM CELL MARKET, BY DRUG DISCOVERY AND DEVELOPMENT, 2021-2028 (IN $ MILLION); FIGURE 33 UNITED STATES STEM CELL MARKET 2021-2028 (IN $ MILLION); FIGURE 34 CANADA STEM CELL MARKET 2021-2028 (IN $ MILLION)